Darifenacin (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Darifenacin drug offered from Actavis Pharma, Inc.. This Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | darifenacin |
SUBSTANCE NAME: | DARIFENACIN HYDROBROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-03-15 |
END MARKETING DATE: | 0000-00-00 |
Darifenacin HUMAN PRESCRIPTION DRUG Details:
Item Description | Darifenacin from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 7.5(mg/1) |
START MARKETING DATE: | 2016-03-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0591-4375_ed88ca2a-2d88-497f-99d4-2c48bfa0ebba |
PRODUCT NDC: | 0591-4375 |
APPLICATION NUMBER: | NDA021513 |
Other DARIFENACIN HYDROBROMIDE Pharmaceutical Manufacturers / Labelers: